IP Library Granted Patent US 10,786,629
Granted Patent B2
US 10,786,629 · App. 15/782,951 · Granted Sep 29, 2020

Drug cassette, autoinjector, and autoinjector system

Inventors: R. Paul Mounce (Burbank, CA); Clinton Judd (Oxnard, CA); Suhas Krishna (Simi Valley, CA); Neal Johnston (Dallas, TX); Gordon Johnston (Dallas, TX); Giorgio Sardo (Milan, IT); Gabriele Ganzitti (Milan, IT); Hong Jun Yeh (Newbury Park, CA)
Assignee: AMGEN INC.
A61M5/3271A61M5/20A61M5/24A61M5/3202A61J1/18A61J2205/60A61M5/3204A61M5/427A61M5/46A61M5/482A61M2005/206A61M2005/208A61M2005/2407A61M2005/2414A61M2005/2481A61M2005/2496A61M2005/3247A61M2205/14A61M2205/192A61M2205/50A61M2205/581A61M2205/6018A61M2205/6027A61M2205/6036A61M2205/6054A61M2205/6063A61M2205/6072A61M2205/6081G09B23/285
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,786,629
App. No.
15/782,951
Granted
Sep 29, 2020
Kind
B2
Abstract

A cassette for use with an injector has a housing, and a cassette identification arrangement (cassette ID) defining a code containing information about the cassette that is detectable and decipherable by an injector. The cassette may further have a sleeve movably disposed within the housing, for holding a drug container, and a locking arrangement for interlocking the sleeve with the housing. The cassette may further have an aperture in the housing, and a cassette cap for removing a needle shield of the drug container. The cassette may have an anti-bending structure to prevent bending or flexing of the cassette cap. The injector may have a processor for controlling operational parameters of the injector and a detector communicatively coupled with the processor for detecting and communicating the cassette ID to the microprocessor to decipher the code defined therein. Also, a method of injecting a drug into a patient with an injector, wherein the sequence of actions performed by the user are controlled. Still further, a method of treating a patient in need thereof wherein a cassette containing a drug is provided and administered to the patient using an injector.

Claims (29)

1. A cassette for an injector, the cassette comprising:

a housing having an aperture;

a drug container disposed in the housing, the drug container having an injection needle and a needle shield disposed over the injection needle;

a cassette cap for removing the needle shield, the cassette cap comprising a generally cylindrical body portion and a key portion disposed adjacent to the cylindrical body portion, the cylindrical body portion engaging the needle shield, the cylindrical body portion having a portion extending through the aperture in the housing configured to be gripped to withdraw the cassette cap from the housing to remove the needle shield; and

an anti-bending structure to prevent bending or flexing of the cassette cap, the anti-bending structure having at least a first member comprising at least a pair of tabs extending outwardly from opposing sides of the key portion and at least a second member on the housing for interacting with the first member.

2. The cassette according to claim 1 , wherein the pair tabs are disposed on side walls of the key portion.

3. The cassette according to claim 1 , wherein the portion of the cylindrical body extending through the aperture in the housing has a gripping flange.

4. The cassette according to claim 1 , wherein the drug container is filled with a drug.

5. The cassette according to claim 4 , wherein the drug comprises a therapeutic product.

6. The cassette according to claim 5 , wherein the therapeutic product is selected from the group consisting of epoetin alfa, darbepoetin alfa, etanercept, pegylated filgastrim, filgrastim, romiplostim, panitumumab, cinacalcet, and denosamab.

7. The cassette according to claim 5 , wherein the therapeutic product is one of (a) an antibody to IL-17 Receptor A, (b) an antagonist of angiopoietin-2, or (c) a TNF blocker or inhibitor.

8. The cassette according to claim 7 , wherein the therapeutic product is a TNF blocker or inhibitor and the TNF blocker or inhibitor is etanercept, adalimumab, certolizumab, golimumab, or infliximab.

9. The cassette according to claim 5 , wherein the therapeutic product has (a) a viscosity of about 19 centipoise at room temperature, (b) a viscosity ranging between about 1 centipoise and about 320 centipoise, at room temperature, (c) a viscosity ranging between about 5 centipoise and about 40 centipoise, at room temperature, (d) a viscosity ranging between about 10 centipoise and about 35 centipoise, at room temperature, (e) a viscosity ranging between about 15 centipoise and about 30 centipoise, at room temperature, (f) a viscosity ranging between about 20 centipoise and about 25 centipoise, at room temperature, (g) a viscosity ranging between about 16 centipoise and about 42 centipoise, at room temperature, or (h) a viscosity ranging between about 1 centipoise and about 29 centipoise, at room temperature.

10. A cassette for an injector, the cassette comprising:

a housing having an aperture;

a drug container disposed in the housing, the drug container having an injection needle and a needle shield disposed over the injection needle;

a cassette cap for removing the needle shield, the cassette cap comprising a generally cylindrical body portion and a key portion disposed adjacent to the cylindrical body portion, the cylindrical body portion engaging the needle shield, the cylindrical body portion having a portion extending through the aperture in the housing configured to be gripped to withdraw the cassette cap from the housing to remove the needle shield; and

an anti-bending structure to prevent bending or flexing of the cassette cap, the anti-bending structure having at least a first member comprising a first pair of tabs extending outwardly from the key portion and a second pair of tabs spaced from the first pair of tabs and at least a second member on the housing for interacting with the first member.

11. The cassette according to claim 10 , wherein the second pair of tabs are disposed on side walls of the key portion.

12. The cassette according to claim 11 , wherein the first and second pairs of tabs extend from outer surfaces of the side walls.

13. The cassette according to claim 10 , wherein the first pair of tabs are disposed adjacent a first end of the key portion and the second pair of tabs are disposed adjacent to a second end of the key portion.

14. A cassette for an injector, the cassette comprising:

a housing having an aperture;

a drug container disposed in the housing, the drug container having an injection needle and a needle shield disposed over the injection needle;

a cassette cap for removing the needle shield, the cassette cap comprising a generally cylindrical body portion and a key portion disposed adjacent to the cylindrical body portion, the cylindrical body portion engaging the needle shield, the cylindrical body portion having a portion extending through the aperture in the housing configured to be gripped to withdraw the cassette cap from the housing to remove the needle shield; and

an anti-bending structure to prevent bending or flexing of the cassette cap, the anti-bending structure having at least a first member comprising a pair of tabs extending outwardly from the key portion and at least a second member on the housing comprising a pair of ribs for interacting with the first member.

15. The cassette according to claim 14 , wherein the pair of ribs are disposed on side walls of the housing.

16. The cassette according to claim 15 , wherein surfaces of the pair of tabs engage surfaces of the pair of ribs.

17. The cassette according to claim 15 , wherein the pair of ribs extend from interior surfaces of the side walls of the housing.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2019
From: JOHNSTON, NEAL D.; JOHNSTON, GORDON; SARDO, GIORGIO; GANZITTI, GABRIELE
To: FLEXTRONICS MEDICAL SALES AND MARKETING, LTD.
Reel/Frame 048414/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2019
From: FLEXTRONICS MEDICAL SALES AND MARKETING, LTD.
To: AMGEN INC
Reel/Frame 048417/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2019
From: MOUNCE, R. PAUL; JUDD, CLINTON; KRISHNA, SUHAS; YEH, HONG JUN
To: AMGEN INC
Reel/Frame 048417/0464 →
Continuity (3)
Continuation 14777255
Provisional Application 61800000 · Mar 15, 2013
Related Publication 20180098914A1 · Apr 12, 2018